Cargando…

Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer

BACKGROUND: It is well established that tumors are antigenic and can induce an immune response by the host, entailing lymphocytic infiltration of the tumor and surrounding stroma. The extent and composition of the immune response to the tumor, assessed through evaluation of tumor-infiltrating lympho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rohan, Thomas E., Arthur, Rhonda, Wang, Yihong, Weinmann, Sheila, Ginsberg, Mindy, Loi, Sherene, Salgado, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846992/ https://www.ncbi.nlm.nih.gov/pubmed/33516237 http://dx.doi.org/10.1186/s13058-021-01395-x

Ejemplares similares

MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer
por: Rohan, Thomas, et al.
Publicado: (2018)

Somatic mutations in benign breast disease tissue and risk of subsequent invasive breast cancer
por: Rohan, Thomas E., et al.
Publicado: (2018)

A Cohort Study of p53 Mutations and Protein Accumulation in Benign Breast Tissue and Subsequent Breast Cancer Risk
por: Kabat, Geoffrey C., et al.
Publicado: (2011)

Immune Infiltration in Invasive Lobular Breast Cancer
por: Desmedt, Christine, et al.
Publicado: (2018)

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
por: Loi, Sherene
Publicado: (2013)

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy
por: Luen, Stephen L., et al.
Publicado: (2019)

Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis
por: Caparica, Rafael, et al.
Publicado: (2021)

Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions
por: Wein, Lironne, et al.
Publicado: (2017)

Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study
por: Rohan, Thomas E, et al.
Publicado: (2021)

Risk factors for breast cancer development by tumor characteristics among women with benign breast disease
por: Figueroa, Jonine D., et al.
Publicado: (2021)

Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer
por: Cui, Yan, et al.
Publicado: (2006)

Relevance of tumor-infiltrating lymphocytes in breast cancer
por: Dushyanthen, Sathana, et al.
Publicado: (2015)

Checkpoint blockade in the treatment of breast cancer: current status and future directions
por: Wein, Lironne, et al.
Publicado: (2018)

Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 update()
por: Brown, Lauren C., et al.
Publicado: (2021)

Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer
por: Zeng, Zexian, et al.
Publicado: (2020)

Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients
por: Soysal, Savas D., et al.
Publicado: (2019)

Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer
por: Jimeno, Rebeca, et al.
Publicado: (2022)

Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer
por: Vellal, Adithya D, et al.
Publicado: (2021)

Triple-negative breast cancer: recent treatment advances
por: Bergin, Alice R T, et al.
Publicado: (2019)

Benign osseous metaplasia of the breast infiltrated by invasive pleomorphic lobular carcinoma: A case report
por: Aljhdali, Hessa, et al.
Publicado: (2022)

Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case–control study
por: Posso, Margarita, et al.
Publicado: (2017)

The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease
por: Beca, Francisco, et al.
Publicado: (2021)

Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?
por: Dixon-Douglas, Julia, et al.
Publicado: (2023)

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
por: Loi, Sherene, et al.
Publicado: (2022)

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data
por: Zardavas, Dimitrios, et al.
Publicado: (2014)

TIGIT as a Novel Prognostic Marker for Immune Infiltration in Invasive Breast Cancer
por: Guo, Chenming, et al.
Publicado: (2023)

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
por: Criscitiello, Carmen, et al.
Publicado: (2010)

Ultrasound breast imaging versus pathology; correlation of reported benign ultrasound scans with subsequent biopsy
por: Sinclair, M
Publicado: (2006)

Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk
por: Almekinders, Mathilde M., et al.
Publicado: (2022)

Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.
por: Whitwell, H. L., et al.
Publicado: (1984)

Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context
por: Abraham, Gad, et al.
Publicado: (2010)

Microenvironmental Influences that Drive Progression from Benign Breast Disease to Invasive Breast Cancer
por: Cichon, Magdalena A., et al.
Publicado: (2010)

Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions
por: David, Steven, et al.
Publicado: (2022)

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.
por: Lee, A. H., et al.
Publicado: (1996)

Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer
por: Nguyen, Bastien, et al.
Publicado: (2019)

Potential immunosuppressive clonal hematopoietic mutations in tumor infiltrating immune cells in breast invasive carcinoma
por: Anandakrishnan, Ramu, et al.
Publicado: (2023)

Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening
por: Rawal, R, et al.
Publicado: (2005)

Benign breast myoepithelioma
por: Khan, L, et al.
Publicado: (2013)

Benign Papilloma of the Breast
por: Sadofsky, Moshe
Publicado: (2017)

Risk of Breast Cancer in Japanese Women with Benign Breast Disease
por: Minami, Yuko, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_np8ium7265245oa1k3qg6ikhlj